How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
What happens when a compliance officer is the whistleblower in a qui tam retaliation lawsuit?
This useful template can be used to develop a clear written policy on time theft for your lab in order to help prevent it.
Six common forms of time theft to be on the lookout for, and how lab leaders can stop each one.
Due to the common misuse of this modifier, the Centers for Medicare & Medicaid Services recently issued important new guidance on its proper use.
This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.
A recent $3.5 million settlement illustrates the kinds of pitfalls that can result in liability for hospital and freestanding sleep labs.
Follow the steps in this form to help you develop and implement an effective healthcare equity plan for your lab.
Recent case shows that fraud and kickback schemes involving CGx testing continue to be on the federal enforcement radar.
As of January 1, 2023, your lab may need to develop and implement a full-blown health equity plan to maintain its Joint Commission accreditation.
Completing the Advance Beneficiary Notice of Noncoverage form can be extremely complex; this guide helps simplify the process.